These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10662962)

  • 21. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
    Silverman DH; Small GW; Chang CY; Lu CS; Kung De Aburto MA; Chen W; Czernin J; Rapoport SI; Pietrini P; Alexander GE; Schapiro MB; Jagust WJ; Hoffman JM; Welsh-Bohmer KA; Alavi A; Clark CM; Salmon E; de Leon MJ; Mielke R; Cummings JL; Kowell AP; Gambhir SS; Hoh CK; Phelps ME
    JAMA; 2001 Nov; 286(17):2120-7. PubMed ID: 11694153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of Alzheimer's disease with PET.
    Salmon E; Sadzot B; Maquet P; Degueldre C; Lemaire C; Rigo P; Comar D; Franck G
    J Nucl Med; 1994 Mar; 35(3):391-8. PubMed ID: 8113882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single-photon emission-computed tomography in the differential diagnosis of dementia].
    Deisenhammer E; Reisecker F; Leblhuber F; Höll K; Markut H; Trenkler J; Schneider I
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1639-44. PubMed ID: 2530079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical studies in Alzheimer patients with positron emission tomography.
    Nordberg A
    Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography in dementia.
    Santens P; Petit H
    Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in degenerative dementias.
    Salmon E; Franck G
    Acta Neurol Belg; 1989; 89(3-4):150-5. PubMed ID: 2516961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects.
    Heiss WD; Herholz K; Pawlik G; Hebold I; Klinkhammer P; Szelies B
    Keio J Med; 1989 Jun; 38(2):111-35. PubMed ID: 2674513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current and future prospects of nuclear medicine in dementia].
    Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
    Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
    Román G; Pascual B
    Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.
    Herholz K
    Expert Rev Neurother; 2010 Nov; 10(11):1667-73. PubMed ID: 20977325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical imaging of Alzheimer's disease and other degenerative dementias.
    Frey KA; Minoshima S; Kuhl DE
    Q J Nucl Med; 1998 Sep; 42(3):166-78. PubMed ID: 9796365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of PET in dementia disorders.
    Nordberg A
    Acta Neurol Scand Suppl; 1996; 168():71-6. PubMed ID: 8997424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional imaging in dementia: an overview.
    Jagust WJ
    J Clin Psychiatry; 1994 Nov; 55 Suppl():5-11. PubMed ID: 7989292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.
    Pietrini P; Alexander GE; Furey ML; Hampel H; Guazzelli M
    Int J Psychophysiol; 2000 Jul; 37(1):87-98. PubMed ID: 10828377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.